Literature DB >> 10762116

Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: report of a 1997 survey. Meningococcal meningitis: 1997 survey report.

L Ragunathan1, M Ramsay, R Borrow, M Guiver, S Gray, E B Kaczmarski.   

Abstract

OBJECTIVES: To describe the epidemiological, clinical and laboratory features of meningococcal meningitis and the effects of antibiotics on laboratory investigations under current clinical practices in England and Wales.
METHODS: Using a telephone questionnaire, information was gathered on 103 cases with a clinical diagnosis of meningococcal meningitis. Included were cases with samples submitted to the Public Health Laboratory Service (PHLS), Meningococcal Reference Unit (MRU) over a 5-month period in 1997. Tests included microscopic examination, latex agglutination and culture for Neisseria meningitidis, and at MRU confirmation of identification and characterization of isolates and meningococcal polymerase chain reaction (PCR) analysis on blood and cerebrospinal fluids (CSF).
RESULTS: Clinically 45% of the cases had predominantly meningitis and 55% had septicaemia and meningitis. Only 29% of the cases received pre-admission benzylpenicillin, and 66% were given antibiotics within an hour of hospital attendance. Microbiological confirmation was achieved in 97 cases, 46 (44%) by traditional tests and 92 (89%) by PCR assay, including some with both. The blood culture positive rate was 23 (22%), but in predominant meningitis the rate was only 10% (5/46). PCR was the sole method of confirmation in 48 cases. Seventy percent of the plasma samples referred were reactive by PCR assay, but all samples taken more than 24 h after hospital antibiotics were non-reactive. PCR-based techniques increased the overall number of cases with a serogroup identified by 44%. Lumbar punctures were performed in 73 of the cases and microbiological confirmation was achieved in 67 (92%) of these cases, compared to 26/30 without lumbar puncture (LP). Eighty-nine percent of the CSF samples referred were reactive by PCR; 50% of the CSF samples taken more than 24 h after hospital antibiotics were reactive, whilst none were positive by culture or microscopy.
CONCLUSION: Due to variable clinical manifestations, early diagnosis and treatment was difficult. Laboratory confirmation has been improved by the introduction of PCR-based techniques. Meningococcal DNA was detected by molecular methods in CSF samples taken up to 72 h after commencement of antibiotics. During this period patients could be stabilized and the chances of complications attendant upon early LP reduced. In addition to providing accurate epidemiological information, confirming the diagnosis may alter the extent and length of follow-up.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762116     DOI: 10.1053/jinf.1999.0595

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  9 in total

1.  Laboratory confirmation of meningococcal disease in Scotland, 1993-9.

Authors:  S C Clarke; J Reid; L Thom; B C Denham; G F S Edwards
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

2.  Evaluation of a rapid PCR assay for diagnosis of meningococcal meningitis.

Authors:  David C Richardson; Lisa Louie; Marie Louie; Andrew E Simor
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 3.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 4.  Invasive meningococcal disease in the 21st century—an update for the clinician.

Authors:  Rachel Dwilow; Sergio Fanella
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

Review 5.  Acute bacterial meningitis in infants and children: epidemiology and management.

Authors:  Shruti Agrawal; Simon Nadel
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

6.  Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children.

Authors:  Penelope A Bryant; Hua Yi Li; Angelo Zaia; Julia Griffith; Geoff Hogg; Nigel Curtis; Jonathan R Carapetis
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Use of a new multiplex quantitative polymerase chain reaction based assay for simultaneous detection of Neisseria meningitidis, Escherichia coli K1 , Streptococcus agalactiae, and Streptococcus pneumoniae.

Authors:  Nastaran Hemmati; Farhad Nikkhahi; Amir Javadi; Sahar Eskandarion; Seyed Mahmoud Amin Marashi
Journal:  Iran J Microbiol       Date:  2021-08

8.  Diagnostic clinical and laboratory findings in response to predetermining bacterial pathogen: data from the Meningitis Registry.

Authors:  Maria Karanika; Vasiliki A Vasilopoulou; Antonios T Katsioulis; Panagiotis Papastergiou; Maria N Theodoridou; Christos S Hadjichristodoulou
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

9.  Identification of Common Bacterial Pathogens Causing Meningitis in Culture-Negative Cerebrospinal Fluid Samples Using Real-Time Polymerase Chain Reaction.

Authors:  Walaa Shawky Khater; Safia Hamed Elabd
Journal:  Int J Microbiol       Date:  2016-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.